Skip to content
2000
Volume 8, Issue 4
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The manipulation of glycosylation, mainly sialylation, holds enormous potential for understanding the biological functions of glycoproteins and glycolipids to treat many diseases. The existing knowledge in the field of glycobiology is exploited by glycotherapeutics for combating protozoan diseases. This review focuses on the development of novel glycobiological therapeutic strategies in the field of protozoan infections.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955708783955980
2008-04-01
2025-09-07

  • From This Site

    /content/journals/mrmc/10.2174/138955708783955980
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955708783955980
Loading

  • Article Type:     Research Article
Keyword(s): Anti-O-acetylated sialoglycoprotein specific antibodies; anti-α-gal antibodies; carbohydrate engineering; drug delivery; engineering inhibitors of glycoproteins; glycotherapeutics; glycovaccine; immunotoxin; metabolite oligosaccharide engineering; oligosaccharide engineering

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test